The purpose of this study is to examine the superiority of YM150 to the placebo and to evaluate the dose-dependent response of YM150 in patients undergoing elective total hip replacement surgery.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Enrollment
610
Unnamed facility
Chugoku, Japan
Unnamed facility
Chūbu, Japan
Unnamed facility
Hokkaido, Japan
Unnamed facility
Kansai, Japan
Overall incidence of venous thromboembolism
Time frame: For 2 weeks
Incidence of individual venous thromboembolism
Time frame: For 2 weeks
Incidence of bleeding events
Time frame: For 2 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Unnamed facility
Kantou, Japan
Unnamed facility
Kyusyu, Japan
Unnamed facility
Shikoku, Japan
Unnamed facility
Tōhoku, Japan
Unnamed facility
Daegu, South Korea
Unnamed facility
Jeonnam, South Korea
...and 6 more locations